Cargando…

An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion

Huntington’s Disease (HD) is a progressive neurodegenerative disorder caused by CAG trinucleotide repeat expansions in exon 1 of the huntingtin (HTT) gene. The mutant HTT (mHTT) protein causes neuronal dysfunction, causing progressive motor, cognitive and behavioral abnormalities. Current treatments...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keller, Caroline Gubser, Shin, Youngah, Monteys, Alex Mas, Renaud, Nicole, Beibel, Martin, Teider, Natalia, Peters, Thomas, Faller, Thomas, St-Cyr, Sophie, Knehr, Judith, Roma, Guglielmo, Reyes, Alejandro, Hild, Marc, Lukashev, Dmitriy, Theil, Diethilde, Dales, Natalie, Cha, Jang-Ho, Borowsky, Beth, Dolmetsch, Ricardo, Davidson, Beverly L., Sivasankaran, Rajeev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894458/ https://www.ncbi.nlm.nih.gov/pubmed/35241644 http://dx.doi.org/10.1038/s41467-022-28653-6

Ejemplares similares

CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
por: Monteys, Alex Mas, et al.
Publicado: (2017)

Pseudoexons of the DMD Gene
por: Keegan, Niall P.
Publicado: (2020)

Haplotyping SNPs for allele-specific gene editing of the expanded huntingtin allele using long-read sequencing
por: Fang, Li, et al.
Publicado: (2022)

Haplotyping SNPs for allele-specific gene editing of the expanded huntingtin allele using long-read sequencing
por: Fang, Li, et al.
Publicado: (2023)

Role of Pseudoexons and Pseudointrons in Human Cancer
por: Romano, Maurizio, et al.
Publicado: (2013)

Orally administered branaplam does not impact neurogenesis in juvenile mice, rats, and dogs
por: Theil, Diethilde, et al.
Publicado: (2021)

MiR-210 promotes sensory hair cell formation in the organ of corti
por: Riccardi, Sabrina, et al.
Publicado: (2016)

A novel dysferlin mutant pseudoexon bypassed with antisense oligonucleotides
por: Dominov, Janice A, et al.
Publicado: (2014)

Comment on: A novel dysferlin-mutant pseudoexon bypassed with antisense oligonucleotides
por: Kergourlay, Virginie, et al.
Publicado: (2015)

Urine mRNA to identify a novel pseudoexon causing dystrophinopathy
por: Antoury, Layal, et al.
Publicado: (2019)

Correction of pseudoexon splicing caused by a novel intronic dysferlin mutation
por: Dominov, Janice A., et al.
Publicado: (2019)

Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing
por: Keegan, Niall P., et al.
Publicado: (2022)

SUMO-2 and PIAS1 Modulate Insoluble Mutant Huntingtin Protein Accumulation
por: O’Rourke, Jacqueline Gire, et al.
Publicado: (2013)

Taking a Break From Huntingtin
por: Davidson, Beverly L
Publicado: (2012)

Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening
por: Kiessling, Michael K., et al.
Publicado: (2016)

Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient
por: Greer, Kane, et al.
Publicado: (2015)

Reply to comment on: A novel dysferlin mutant pseudoexon bypassed with antisense oligonucleotides
por: Dominov, Janice A, et al.
Publicado: (2015)

Novel Intronic Mutations Introduce Pseudoexons in DMD That Cause Muscular Dystrophy in Patients
por: Lu, Xinguo, et al.
Publicado: (2021)

Corrigendum: Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing
por: Keegan, Niall P., et al.
Publicado: (2022)

Antisense Oligonucleotide Rescue of Deep-Intronic Variants Activating Pseudoexons in the 6-Pyruvoyl-Tetrahydropterin Synthase Gene
por: Martínez-Pizarro, Ainhoa, et al.
Publicado: (2022)

Pseudoexons provide a mechanism for allele-specific expression of APC in familial adenomatous polyposis
por: Nieminen, Taina T., et al.
Publicado: (2016)

Antisense Morpholino-Based In Vitro Correction of a Pseudoexon-Generating Variant in the SGCB Gene
por: Magri, Francesca, et al.
Publicado: (2022)

An in‐frame pseudoexon activation caused by a novel deep‐intronic variant in the dysferlin gene
por: Sun, Chengyue, et al.
Publicado: (2022)

SpliceAI-10k calculator for the prediction of pseudoexonization, intron retention, and exon deletion
por: Canson, Daffodil M, et al.
Publicado: (2023)

RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events
por: Buratti, Emanuele, et al.
Publicado: (2007)

NNT Pseudoexon Activation as a Novel Mechanism for Disease in Two Siblings With Familial Glucocorticoid Deficiency
por: Novoselova, Tatiana V., et al.
Publicado: (2015)

Exon-centric regulation of ATM expression is population-dependent and amenable to antisense modification by pseudoexon targeting
por: Kralovicova, Jana, et al.
Publicado: (2016)

Splicing Characteristics of Dystrophin Pseudoexons and Identification of a Novel Pathogenic Intronic Variant in the DMD Gene
por: Xie, Zhiying, et al.
Publicado: (2020)

Corrigendum: Exon-centric regulation of ATM expression is population-dependent and amenable to antisense modification by pseudoexon targeting
por: Kralovicova, Jana, et al.
Publicado: (2016)

GHR gene transcript heterogeneity may explain phenotypic variability in GHR pseudoexon (6Ψ) patients
por: Chatterjee, Sumana, et al.
Publicado: (2020)

Huntingtin and the Synapse
por: Barron, Jessica C., et al.
Publicado: (2021)

Complete androgen insensitivity syndrome caused by a deep intronic pseudoexon-activating mutation in the androgen receptor gene
por: Känsäkoski, Johanna, et al.
Publicado: (2016)

A comprehensive assessment of RNA-seq protocols for degraded and low-quantity samples
por: Schuierer, Sven, et al.
Publicado: (2017)

RNAi prevents and reverses phenotypes induced by mutant human ataxin‐1
por: Keiser, Megan S., et al.
Publicado: (2016)

A Huntingtin Peptide Inhibits PolyQ-Huntingtin Associated Defects
por: Arribat, Yoan, et al.
Publicado: (2013)

The evolution of the huntingtin-associated protein 40 (HAP40) in conjunction with huntingtin
por: Seefelder, Manuel, et al.
Publicado: (2020)

Growth Hormone Receptor (GHR) 6Ω Pseudoexon Activation: A Novel Cause of Severe Growth Hormone Insensitivity
por: Cottrell, Emily, et al.
Publicado: (2021)

Linking Huntingtin to motility
por: Tuma, Rabiya S.
Publicado: (2006)

Huntingtin Lowering Strategies
por: Marxreiter, Franz, et al.
Publicado: (2020)

Dual Role of G-runs and hnRNP F in the Regulation of a Mutation-Activated Pseudoexon in the Fibrinogen Gamma-Chain Transcript
por: Rimoldi, Valeria, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4enthb0m1i0dsirrt5us3t24ns